415 related articles for article (PubMed ID: 25505143)
1. An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.
Peng W; Feng M; Feng X; Liang YX; She Q
Nucleic Acids Res; 2015 Jan; 43(1):406-17. PubMed ID: 25505143
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
[TBL] [Abstract][Full Text] [Related]
3. A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction.
Han W; Li Y; Deng L; Feng M; Peng W; Hallstrøm S; Zhang J; Peng N; Liang YX; White MF; She Q
Nucleic Acids Res; 2017 Feb; 45(4):1983-1993. PubMed ID: 27986854
[TBL] [Abstract][Full Text] [Related]
4. A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.
Pan S; Li Q; Deng L; Jiang S; Jin X; Peng N; Liang Y; She Q; Li Y
RNA Biol; 2019 Sep; 16(9):1166-1178. PubMed ID: 31096876
[TBL] [Abstract][Full Text] [Related]
5. Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA.
Li Y; Zhang Y; Lin J; Pan S; Han W; Peng N; Liang YX; She Q
Nucleic Acids Res; 2017 Nov; 45(19):11305-11314. PubMed ID: 28977458
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
7. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis.
Elmore JR; Yokooji Y; Sato T; Olson S; Glover CV; Graveley BR; Atomi H; Terns RM; Terns MP
RNA Biol; 2013 May; 10(5):828-40. PubMed ID: 23535213
[TBL] [Abstract][Full Text] [Related]
8. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
[TBL] [Abstract][Full Text] [Related]
9. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
[TBL] [Abstract][Full Text] [Related]
10. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
[TBL] [Abstract][Full Text] [Related]
11. In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex.
Plagens A; Tripp V; Daume M; Sharma K; Klingl A; Hrle A; Conti E; Urlaub H; Randau L
Nucleic Acids Res; 2014 Apr; 42(8):5125-38. PubMed ID: 24500198
[TBL] [Abstract][Full Text] [Related]
12. A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus.
Deng L; Garrett RA; Shah SA; Peng X; She Q
Mol Microbiol; 2013 Mar; 87(5):1088-99. PubMed ID: 23320564
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.
Yu Z; Jiang S; Wang Y; Tian X; Zhao P; Xu J; Feng M; She Q
Sci China Life Sci; 2021 May; 64(5):678-696. PubMed ID: 33140167
[TBL] [Abstract][Full Text] [Related]
14. Coupling transcriptional activation of CRISPR-Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus.
Liu T; Liu Z; Ye Q; Pan S; Wang X; Li Y; Peng W; Liang Y; She Q; Peng N
Nucleic Acids Res; 2017 Sep; 45(15):8978-8992. PubMed ID: 28911114
[TBL] [Abstract][Full Text] [Related]
15. Major and minor crRNA annealing sites facilitate low stringency DNA protospacer binding prior to Type I-A CRISPR-Cas interference in Sulfolobus.
Mousaei M; Deng L; She Q; Garrett RA
RNA Biol; 2016 Nov; 13(11):1166-1173. PubMed ID: 27618562
[TBL] [Abstract][Full Text] [Related]
16. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
[TBL] [Abstract][Full Text] [Related]
17. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
Sheppard NF; Glover CV; Terns RM; Terns MP
RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
[TBL] [Abstract][Full Text] [Related]
18. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-mediated defense mechanisms in the hyperthermophilic archaeal genus Sulfolobus.
Manica A; Schleper C
RNA Biol; 2013 May; 10(5):671-8. PubMed ID: 23535277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
